|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, Angeles C and Menendez LR: A
meta-analysis of osteosarcoma outcomes in the modern medical era.
Sarcoma. 2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JA, Kim DH, Lim JS, Park KD, Song WS,
Lee SY and Jeon DG: The survival of osteosarcoma patients 10 years
old or younger is not worse than the survival of older patients: A
retrospective analysis. Cancer Res Treat. 39:160–164. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu B, Peng XC, Zheng XL, Wang J and Qin
YW: MiR-126 restoration down-regulate VEGF and inhibit the growth
of lung cancer cell lines in vitro and in vivo. Lung Cancer.
66:169–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu W, Zhao X, Zhang YJ, Fang GW and Xue
Y: MicroRNA-375 as a potential serum biomarker for the diagnosis,
prognosis, and chemosensitivity prediction of osteosarcoma. J Int
Med Res. 46:975–983. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie Y, Sun W, Deng Z, Zhu X, Hu C and Cai
L: miR-302b suppresses osteosarcoma cell migration and invasion by
targeting Runx2. Sci Rep. 7:133882017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji Q, Xu X, Li L, Goodman SB, Bi W, Xu M,
Xu Y, Fan Z, Maloney WJ, Ye Q, et al: miR-216a inhibits
osteosarcoma cell proliferation, invasion and metastasis by
targeting CDK14. Cell Death Dis. 8:e31032017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Z, Liu Q, Hong H, Zhang H and Zhang T:
miR-19 promotes osteosarcoma progression by targeting SOCS6.
Biochem Biophys Res Commun. 495:1363–1369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu Q, Zhou W, Feng Q, Liu X, Xiong Y and
Li H: MicroRNA-92b promotes cell proliferation and invasion in
osteosarcoma by directly targeting Dickkopf-related protein 3. Exp
Ther Med. 15:173–181. 2018.PubMed/NCBI
|
|
13
|
Zhou C, Jiang CQ, Zong Z, Lin JC and Lao
LF: miR-146a promotes growth of osteosarcoma cells by targeting
ZNRF3/GSK-3β/β-catenin signaling pathway. Oncotarget.
8:74276–74286. 2017.PubMed/NCBI
|
|
14
|
Zhao Y, Li C, Wang M, Su L, Qu Y, Li J, Yu
B, Yan M, Yu Y, Liu B, et al: Decrease of miR-202-3p expression, a
novel tumor suppressor, in gastric cancer. PLoS One. 8:e697562013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Q, Huang Z, Guo W, Ni S, Xiao X, Wang
L, Huang D, Tan C, Xu Q, Zha R, et al: microRNA-202-3p inhibits
cell proliferation by targeting ADP-ribosylation factor-like 5A in
human colorectal carcinoma. Clin Cancer Res. 20:1146–1157. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng X, Hou C, Liang Z, Wang H, Zhu L and
Xu H: miR-202 suppresses cell proliferation by targeting FOXR2 in
endometrial adenocarcinoma. Dis Markers. 2017:28274352017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu
X, Wu J, Zhu Y, Zheng X, et al: MicroRNA-124-3p inhibits cell
migration and invasion in bladder cancer cells by targeting ROCK1.
J Transl Med. 11:2762013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai SD, Chen JS, Xi ZW, Zhang LJ, Niu ML
and Gao ZY: MicroRNA 144 inhibits migration and proliferation in
rectal cancer by downregulating ROCK 1. Mol Med Rep. 12:7396–7402.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Song Y, Wang Y, Luo J and Yu W:
MicroRNA-148a suppresses epithelial-to-mesenchymal transition by
targeting ROCK1 in non-small cell lung cancer cells. Mol Cell
Biochem. 380:277–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng M, Sun X, Li Y and Zuo W:
MicroRNA-145 inhibits growth and migration of breast cancer cells
through targeting oncoprotein ROCK1. Tumour Biol. 37:8189–8196.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Choy E, Hornicek FJ, Yang S, Yang
C, Harmon D, Mankin H and Duan Z: ROCK1 as a potential therapeutic
target in osteosarcoma. J Orthop Res. 29:1259–1266. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cong C, Wang W, Tian J, Gao T, Zheng W and
Zhou C: Identification of serum miR-124 as a biomarker for
diagnosis and prognosis in osteosarcoma. Cancer Biomark.
21:449–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meng X, Chen X, Lu P, Ma W, Yue D, Song L
and Fan Q: MicroRNA-202 inhibits tumor progression by targeting
LAMA1 in esophageal squamous cell carcinoma. Biochem Biophys Res
Commun. 473:821–827. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Zheng D, Xiong Y, Xue C, Chen G,
Yan B and Ye Q: miR-202 suppresses cell proliferation in human
hepatocellular carcinoma by downregulating LRP6
post-transcriptionally. FEBS Lett. 588:1913–1920. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao Z, Lv B, Zhang L, Zhao N and Lv Y:
miR-202 functions as a tumor suppressor in non-small cell lung
cancer by targeting STAT3. Mol Med Rep. 16:2281–2289. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun Z, Zhang T, Hong H, Liu Q and Zhang H:
miR-202 suppresses proliferation and induces apoptosis of
osteosarcoma cells by downregulating Gli2. Mol Cell Biochem.
397:277–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou F, Li Y, Hao Z, Liu X, Chen L, Cao Y,
Liang Z, Yuan F, Liu J, Wang J, et al: MicroRNA-300 inhibited
glioblastoma progression through ROCK1. Oncotarget. 7:36529–36538.
2016.PubMed/NCBI
|
|
30
|
Maskey N, Li D, Xu H, Song H, Wu C, Hua K,
Song J and Fang L: MicroRNA-340 inhibits invasion and metastasis by
downregulating ROCK1 in breast cancer cells. Oncol Lett.
14:2261–2267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xue H, Guo X, Han X, Yan S, Zhang J, Xu S,
Li T, Guo X, Zhang P, Gao X, et al: MicroRNA-584-3p, a novel tumor
suppressor and prognostic marker, reduces the migration and
invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Oncotarget. 7:4785–4805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Majid S, Dar AA, Saini S, Shahryari V,
Arora S, Zaman MS, Chang I, Yamamura S, Chiyomaru T, Fukuhara S, et
al: MicroRNA-1280 inhibits invasion and metastasis by targeting
ROCK1 in bladder cancer. PLoS One. 7:e467432012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lei P, Xie J, Wang L, Yang X, Dai Z and Hu
Y: microRNA-145 inhibits osteosarcoma cell proliferation and
invasion by targeting ROCK1. Mol Med Rep. 10:155–160. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang S, Zhao Y and Wang L: MicroRNA-198
inhibited tumorous behaviors of human osteosarcoma through directly
targeting ROCK1. Biochem Biophys Res Commun. 472:557–565. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Y, Wang N, Zeng X, Sun J, Wang G, Xu
H and Zhao W: MicroRNA-335 and its target Rock1 synergistically
influence tumor progression and prognosis in osteosarcoma. Oncol
Lett. 13:3057–3065. 2017. View Article : Google Scholar : PubMed/NCBI
|
